117 related articles for article (PubMed ID: 7756714)
1. Sulpiride: an antipsychotic with selective dopaminergic antagonist properties.
Caley CF; Weber SS
Ann Pharmacother; 1995 Feb; 29(2):152-60. PubMed ID: 7756714
[TBL] [Abstract][Full Text] [Related]
2. Ziprasidone: the fifth atypical antipsychotic.
Caley CF; Cooper CK
Ann Pharmacother; 2002 May; 36(5):839-51. PubMed ID: 11978164
[TBL] [Abstract][Full Text] [Related]
3. An evaluation of a unique new antipsychotic agent, sulpiride: effects on serum prolactin and growth hormone levels.
Mielke DH; Gallant DM; Kessler C
Am J Psychiatry; 1977 Dec; 134(12):1371-5. PubMed ID: 21571
[TBL] [Abstract][Full Text] [Related]
4. A risk-benefit assessment of sulpiride in the treatment of schizophrenia.
Mauri MC; Bravin S; Bitetto A; Rudelli R; Invernizzi G
Drug Saf; 1996 May; 14(5):288-98. PubMed ID: 8800626
[TBL] [Abstract][Full Text] [Related]
5. Clinical implications of dopamine research in schizophrenia.
Pani L
Curr Med Res Opin; 2002; 18 Suppl 3():s3-7. PubMed ID: 12418605
[TBL] [Abstract][Full Text] [Related]
6. Sulpiride in tardive dyskinesia.
Casey DE; Gerlach J; Simmelsgaard H
Psychopharmacology (Berl); 1979; 66(1):73-7. PubMed ID: 44375
[TBL] [Abstract][Full Text] [Related]
7. Is amisulpride an 'atypical' atypical antipsychotic agent?
Lecrubier Y
Int Clin Psychopharmacol; 2000 Dec; 15 Suppl 4():S21-6. PubMed ID: 11252520
[TBL] [Abstract][Full Text] [Related]
8. Sulpiride in tardive dyskinesia.
Gerlach J; Casey DE
Acta Psychiatr Scand Suppl; 1984; 311():93-102. PubMed ID: 6142590
[TBL] [Abstract][Full Text] [Related]
9. [Clinical-neuroleptic investigation of N-((1-ethyl-pyrrolidine-2-yl)-methyl)-2-methoxy-5-sulfamyl-benzamide-neuroleptic sulpiride (Dogmatil) in acutly ill schizophrenics].
Haase HJ; Floru L; Ulrich F
Int Pharmacopsychiatry; 1974; 9(2):77-94. PubMed ID: 4603413
[No Abstract] [Full Text] [Related]
10. [Toxicity of sulpiride].
Ciszowski K; Szpak D; Wilimowska J
Przegl Lek; 2010; 67(8):606-9. PubMed ID: 21387787
[TBL] [Abstract][Full Text] [Related]
11. Sulpiride-induced tardive dystonia.
Miller LG; Jankovic J
Mov Disord; 1990; 5(1):83-4. PubMed ID: 1967484
[TBL] [Abstract][Full Text] [Related]
12. Serotonergic modulation of dopamine neurotransmission: a mechanism for enhancing therapeutics in schizophrenia.
Haleem DJ
J Coll Physicians Surg Pak; 2006 Aug; 16(8):556-62. PubMed ID: 16899192
[TBL] [Abstract][Full Text] [Related]
13. Review of clinical and laboratory experiences with molindone hydrochloride.
Claghorn JL
J Clin Psychiatry; 1985 Aug; 46(8 Pt 2):30-3. PubMed ID: 3894340
[TBL] [Abstract][Full Text] [Related]
14. Pharmacologic treatment of schizophrenia.
Levinson DF
Clin Ther; 1991; 13(3):326-52. PubMed ID: 1683269
[TBL] [Abstract][Full Text] [Related]
15. Amisulpride a selective dopamine antagonist and atypical antipsychotic: results of a meta-analysis of randomized controlled trials.
Leucht S
Int J Neuropsychopharmacol; 2004 Mar; 7 Suppl 1():S15-20. PubMed ID: 14972080
[TBL] [Abstract][Full Text] [Related]
16. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? an in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients.
Bressan RA; Erlandsson K; Jones HM; Mulligan R; Flanagan RJ; Ell PJ; Pilowsky LS
Am J Psychiatry; 2003 Aug; 160(8):1413-20. PubMed ID: 12900302
[TBL] [Abstract][Full Text] [Related]
17. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
18. Amisulpride, an unusual "atypical" antipsychotic: a meta-analysis of randomized controlled trials.
Leucht S; Pitschel-Walz G; Engel RR; Kissling W
Am J Psychiatry; 2002 Feb; 159(2):180-90. PubMed ID: 11823257
[TBL] [Abstract][Full Text] [Related]
19. A double blind trial of sulpiride in Huntington's disease and tardive dyskinesia.
Quinn N; Marsden CD
J Neurol Neurosurg Psychiatry; 1984 Aug; 47(8):844-7. PubMed ID: 6236286
[TBL] [Abstract][Full Text] [Related]
20. Olanzapine: a new antipsychotic agent with efficacy in the management of schizophrenia.
Kando JC; Shepski JC; Satterlee W; Patel JK; Reams SG; Green AI
Ann Pharmacother; 1997 Nov; 31(11):1325-34. PubMed ID: 9391688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
